​

Tonix Pharmaceuticals Ownership | Who Owns Tonix Pharmaceuticals?

OverviewRevenueFinancialsChart

Tonix Pharmaceuticals Ownership Summary

100.00% retail investors. Extended Equity Market Fund K is the top mutual fund, with 0.22% of its assets in Tonix Pharmaceuticals shares.

TNXP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTonix Pharmaceuticals--100.00%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20231-97.22%7-100.00%----100.00%--100.00%
Mar 31, 202336-2.70%7,625,492-17.71%183.72%16-30.43%8-
Dec 31, 20223737.04%9,266,62165.84%2212.45%2335.29%8100.00%
Sep 30, 202227-27.03%5,587,58528.60%133.54%17-52.78%4-
Jun 30, 2022373600.00%4,344,95862070728.57%19-363500.00%--

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Extended Equity Market Fund K406.06K0.22%406.06K
NT Ext Equity Mkt Idx Fd - NL267.67K0.14%267.47K
NT Ext Equity Mkt Idx Fd - L212.22K0.11%209.53K
NT Ext Equity Mkt Idx Fd - DC - NL - T2212.15K0.11%211.99K
Fidelity Extended Market Index112.39K0.06%-741.00
Extended Equity Market Fund M52.75K0.03%52.75K
NT Ext Eq Mkt Indx Fd DC Lend T450.57K0.03%50.57K
NT Ext Eq Mkt Indx Fd DC Lend T350.57K0.03%50.57K
Vanguard Total Stock Mkt Idx Inv18.09K0.01%-
State St US Ttl Mkt Indx SL Cl I22.61K0.01%22.60K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 29, 2022LEDERMAN SETH Chief Executive OfficerBuy$34.20K
Mar 25, 2022LEDERMAN SETH Chief Executive OfficerBuy$24.50K
Sep 28, 2021LEDERMAN SETH Chief Executive OfficerBuy$7.32K
May 25, 2021Goodman Daniel Wintner-Buy$5.60K
Mar 24, 2021LEDERMAN SETH Chief Executive OfficerBuy$22.09K

Insider Transactions Trends

DateBuySell
2024 Q2--
2024 Q1--
2023 Q2--
2023 Q1--
2022 Q21-

TNXP Ownership FAQ

Who Owns Tonix Pharmaceuticals?

Tonix Pharmaceuticals shareholders are primarily institutional investors at 0%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Tonix Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Tonix Pharmaceuticals falls below.

Does Blackrock own Tonix Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Tonix Pharmaceuticals.

Who is the top mutual fund holder of Tonix Pharmaceuticals shares?

Extended Equity Market Fund K is the top mutual fund holder of Tonix Pharmaceuticals shares, with 0.22% of its total shares outstanding invested in 406.06K Tonix Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools